World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
45905
World Ranking
6986
National Ranking
3673

Edward A. Stadtmauer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edward A. Stadtmauer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 584 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Edward A. Stadtmauer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edward A. Stadtmauer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Edward A. Stadtmauer is affiliated with the University of Pennsylvania in the United States and has made significant contributions to the field of medicine, with a strong focus on hematology, oncology, molecular biology, genetics, and immunology.

Their research covers a range of topics including:

  • Multiple Myeloma Research and Treatments
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Protein Degradation and Inhibitors
  • Acute Myeloid Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia research

Frequent co-authors collaborating with Edward A. Stadtmauer include:

  • Alfred L. Garfall
  • Dan T. Vogl
  • Adam D. Cohen
  • Adam Waxman
  • Sandra P. Susanibar-Adaniya

Their research has been published extensively in notable venues such as:

  • Blood
  • Transplantation and Cellular Therapy
  • Journal of Clinical Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Bone Marrow Transplantation

Selected recent papers authored or co-authored by Edward A. Stadtmauer include:

  • "CRISPR-engineered T cells in patients with refractory cancer," 2020, Science
  • "T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy," 2024, Nature Medicine
  • "Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set," 2020, Blood
  • "Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia," 2020, Journal of Clinical Oncology
  • "Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells," 2023, Cell

Best Publications

  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin

  • Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

    Donna M. Weber;Christine Chen;Ruben Niesvizky;Michael Wang

  • CRISPR-engineered T cells in patients with refractory cancer

    Edward A. Stadtmauer;Joseph A. Fraietta;Megan M. Davis;Adam D. Cohen

  • Lenalidomide after stem-cell transplantation for multiple myeloma

    Philip L. McCarthy;Kouros Owzar;Craig C. Hofmeister;David D. Hurd

  • Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

    Gerald P. Linette;Edward A. Stadtmauer;Marcela V. Maus;Aaron P. Rapoport

  • Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

    Eric L. Sievers;Richard A. Larson;Edward A. Stadtmauer;Elihu Estey

  • bcl-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia

    Motoi Hanada;Domenico Delia;Antonella Aiello;Edward Stadtmauer

  • NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

    Aaron P Rapoport;Edward A Stadtmauer;Gwendolyn K Binder-Scholl;Olga Goloubeva

  • Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Richard I. Fisher;Steven H. Bernstein;Brad S. Kahl;Benjamin Djulbegovic

  • Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

    John F. DiPersio;Edward A. Stadtmauer;Auayporn Nademanee;Ivana N.M. Micallef

  • A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

    David S. Siegel;Thomas Martin;Michael Wang;Ravi Vij

  • B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma

    Adam D. Cohen;Alfred L. Garfall;Edward A. Stadtmauer;J. Joseph Melenhorst

  • Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells

    Brian J. Cameron;Andrew B. Gerry;Joseph Dukes;Jane V. Harper

  • Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

    Alfred L. Garfall;Marcela V. Maus;Wei-Ting Hwang;Simon F. Lacey

  • Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.

    Paul Gerard Richardson;Pieter Sonneveld;Michael Schuster;David Irwin

  • A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

    JM Rowe;JW Andersen;JJ Mazza;JM Bennett

  • Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

    Edward A. Stadtmauer;Anne O'Neill;Lori J. Goldstein;Pamela A. Crilley

  • Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma.

    M A Dimopoulos;C Chen;A Spencer;R Niesvizky

  • Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

    Richard A. Larson;Eric L. Sievers;Eric L. Sievers;Edward A. Stadtmauer;Bob Löwenberg

  • Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

    John R. Wingard;Shelly L. Carter;Thomas J. Walsh;Joanne Kurtzberg

Frequent Co-Authors

David L. Porter
David L. Porter University of Pennsylvania
Carl H. June
Carl H. June University of Pennsylvania
Bruce L. Levine
Bruce L. Levine University of Pennsylvania
Marcelo C. Pasquini
Marcelo C. Pasquini Medical College of Wisconsin
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Paul G. Richardson
Paul G. Richardson Harvard University
Parameswaran Hari
Parameswaran Hari Medical College of Wisconsin
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Rosemarie Mick
Rosemarie Mick University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens many doors beyond becoming a doctor. For those interested in healthcare management and leadership roles, earning the cheapest online master degree in healthcare administration can be a smart move. These programs focus on developing skills in healthcare policy, finance, and operations, offering flexibility for working professionals.

Nursing professionals seeking advancement can consider dnp online programs cheap. A Doctor of Nursing Practice (DNP) supports clinical expertise and leadership in advanced practice nursing, often leading to higher salaries and top-tier healthcare roles.

Pharmacists or those aiming for pharmacy roles may benefit from accredited online pharmd programs. These programs are ideal for advancing practice while balancing work and study, emphasizing pharmaceutical care, clinical practice, and patient safety.

Finally, tech-savvy students can explore online health information management degree programs. These degrees offer pathways into the growing field of health data, records management, and health informatics.

Together, these related online degree options provide multiple routes to impactful, high-demand careers in healthcare—all with the convenience and affordability of online study.

Best Scientists Citing Edward A. Stadtmauer

Trending Scientists

Recently Published Articles